Skip to main content
. Author manuscript; available in PMC: 2016 Feb 12.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2014 Aug 4;90(2):270–277. doi: 10.1016/j.ijrobp.2014.05.053

Figure 1.

Figure 1

Diagram of participants and sample evolution: This is a flow chart of the evaluable patients grouped by analysis (No. 1 and 2) indicating the number of patients with analyzable QOL instruments at each subsequent step and time-point. “Other” refers to one patient removed from study due to non-compliance with treatment protocol.